National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, 188 Shizi Street, Suzhou, Jiangsu Province, 215006, China.
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 288 Nanjing Road, Tianjin, China.
BMC Health Serv Res. 2024 Mar 12;24(1):326. doi: 10.1186/s12913-024-10829-z.
In the past 40 years, China has experienced tremendous economic development, but the current situation of hematologists has rarely been reported. A landscape survey of human resources is essential for healthcare development and policy formulation in the future.
The Chinese Society of Hematology initiated a survey of Chinese hematologists in mainland China for evaluating demographic and practice characteristics. Respondents were anonymous, and there were no limitations regarding their age, sex, etc. RESULTS: Totally 2032 hematologists responded, with a median age bracket of 36-45 years. Respondents were well engaged into subspecialties, and 28.1% acquired doctorates of philosophy. Hematopoietic cell transplantation (HCT) centers have been established all over China. Higher-GDP regions reported more advantages, including bigger scale of transplant centers (P < 0.001), younger age structure (P = 0.039), better education qualifications (P = 0.001) and less turnover intentions (P = 0.004), despite of increased risk of medical disputes (P = 0.028). Although females accounted for 65.5% of hematologists, males were older (P < 0.001), and had more senior professional titles (P < 0.001), academic positions (P < 0.001), opportunities for continuing education (P < 0.001), and paper publishing in the recent two years (P = 0.001). For turnover intention, the higher GDP regions led to an independently reduced risk (HR = 0.673, 95%CI [0.482-0.940], P = 0.020), whereas medical disputes resulted in an increased the risk (HR = 2.037, 95%CI [1.513-2.743], P < 0.001). Considering the impact of the COVID-19 pandemic, majority of respondents believed that the decline in patient visits and delay in treatment was within 30%. 67.9% of respondents reported a decrease of the use of bone marrow as grafts but 18.8% reported an increase of cord blood units. 35.0% of the respondents switched their daily work to support the anti-epidemic medical activities.
We concluded the discipline of hematology in China has flourished in recent years with a young workforce, while regional economic and gender disparities warrant further continuous optimization. Joint efforts against the impact of COVID-19 are needed in the post-pandemic era.
在过去的 40 年里，中国经历了巨大的经济发展，但目前很少有关于血液学家现状的报道。对人力资源进行全景调查对于未来的医疗保健发展和政策制定至关重要。
中华血液学分会发起了一项中国大陆血液学家的调查，以评估人口统计学和实践特征。受访者是匿名的，他们的年龄、性别等没有限制。
共有 2032 名血液学家做出回应，中位年龄在 36-45 岁之间。受访者广泛从事亚专科工作，其中 28.1%获得了博士学位。造血细胞移植（HCT）中心已遍布全国。高 GDP 地区报告了更多优势，包括更大的移植中心规模（P < 0.001）、更年轻的年龄结构（P = 0.039）、更好的教育资质（P = 0.001）和更低的离职意愿（P = 0.004），尽管医疗纠纷风险增加（P = 0.028）。尽管女性血液学家占 65.5%，但男性年龄更大（P < 0.001），拥有更高级别的专业职称（P < 0.001）、学术职位（P < 0.001）、继续教育机会（P < 0.001）和近两年的论文发表（P = 0.001）。对于离职意愿，较高的 GDP 地区独立降低了风险（HR = 0.673，95%CI [0.482-0.940]，P = 0.020），而医疗纠纷增加了风险（HR = 2.037，95%CI [1.513-2.743]，P < 0.001）。考虑到 COVID-19 大流行的影响，大多数受访者认为患者就诊减少和治疗延迟在 30%以内。67.9%的受访者报告骨髓作为移植物的使用减少，但 18.8%的受访者报告脐带血单位增加。35.0%的受访者将日常工作转向支持抗疫医疗活动。
我们得出结论，近年来，中国血液学领域蓬勃发展，拥有一支年轻的劳动力队伍，而区域经济和性别差距需要进一步持续优化。在后疫情时代，需要共同努力应对 COVID-19 的影响。
